J2KBIO Co., Ltd. (KOSDAQ:420570)
7,670.00
-350.00 (-4.36%)
At close: Nov 6, 2026
| Market Cap | 44.85B -9.2% |
| Revenue (ttm) | 43.90B +51.0% |
| Net Income | 5.81B +401.8% |
| EPS | 994.22 +391.7% |
| Shares Out | 5.85M |
| PE Ratio | 7.71 |
| Forward PE | n/a |
| Dividend | 250.00 (3.26%) |
| Ex-Dividend Date | Dec 29, 2025 |
| Volume | 18,661 |
| Open | 7,890.00 |
| Previous Close | 8,020.00 |
| Day's Range | 7,400.00 - 7,900.00 |
| 52-Week Range | 6,710.00 - 12,860.00 |
| Beta | 0.51 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 12, 2026 |